| Coronavirus membrane fusion mechanism offers a potential target for antiviral development T Tang, M Bidon, JA Jaimes, GR Whittaker, S Daniel Antiviral research 178, 104792, 2020 | 869 | 2020 |
| SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group YL Kwong, WS Kim, ST Lim, SJ Kim, T Tang, E Tse, AYH Leung, CS Chim Blood, The Journal of the American Society of Hematology 120 (15), 2973-2980, 2012 | 471 | 2012 |
| Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma TL Song, ML Nairismägi, Y Laurensia, JQ Lim, J Tan, ZM Li, WL Pang, ... Blood, The Journal of the American Society of Hematology 132 (11), 1146-1158, 2018 | 318 | 2018 |
| Janus kinase 3–activating mutations identified in natural killer/T-cell Lymphoma GC Koo, SY Tan, T Tang, SL Poon, GE Allen, L Tan, SC Chong, WS Ong, ... Cancer discovery 2 (7), 591-597, 2012 | 302 | 2012 |
| Missing the point (er): On the effectiveness of code pointer integrity I Evans, S Fingeret, J Gonzalez, U Otgonbaatar, T Tang, H Shrobe, ... 2015 IEEE Symposium on Security and Privacy, 781-796, 2015 | 242 | 2015 |
| Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B. 1.1. 7 (Alpha) spike B Lubinski, MHV Fernandes, L Frazier, T Tang, S Daniel, DG Diel, ... Iscience 25 (1), 2022 | 207* | 2022 |
| Type II enteropathy‐associated T‐cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group E Tse, H Gill, F Loong, SJ Kim, SB Ng, T Tang, YH Ko, WJ Chng, ST Lim, ... American journal of hematology 87 (7), 663-668, 2012 | 186 | 2012 |
| Proteolytic activation of SARS-CoV-2 spike at the S1/S2 boundary: potential role of proteases beyond furin T Tang, JA Jaimes, MK Bidon, MR Straus, S Daniel, GR Whittaker ACS Infectious Diseases 7 (2), 264-272, 2021 | 156 | 2021 |
| JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma ML Nairismägi, J Tan, JQ Lim, S Nagarajan, CCY Ng, V Rajasegaran, ... Leukemia 30 (6), 1311-1319, 2016 | 155 | 2016 |
| Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype SY Tan, SS Chuang, T Tang, L Tan, YH Ko, KL Chuah, SB Ng, WJ Chng, ... Leukemia 27 (8), 1688-1696, 2013 | 139 | 2013 |
| Myocardial infarction in the C57BL/6J mouse: a quantifiable and highly reproducible experimental model M Salto-Tellez, SY Lim, RM El Oakley, TPL Tang, ZAM ALmsherqi, SK Lim Cardiovascular Pathology 13 (2), 91-97, 2004 | 134 | 2004 |
| Ca2+ Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity MR Straus, T Tang, AL Lai, A Flegel, M Bidon, JH Freed, S Daniel, ... Journal of virology 94 (13), 10.1128/jvi. 00426-20, 2020 | 129 | 2020 |
| HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response B Rotblat, AL Southwell, DE Ehrnhoefer, NH Skotte, M Metzler, ... Proceedings of the National Academy of Sciences 111 (8), 3032-3037, 2014 | 111 | 2014 |
| Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study Z Li, Y Xia, LN Feng, JR Chen, HM Li, J Cui, QQ Cai, KS Sim, ... The Lancet Oncology 17 (9), 1240-1247, 2016 | 103 | 2016 |
| Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T … SJ Kim, JY Choi, SH Hyun, CS Ki, D Oh, YC Ahn, YH Ko, S Choi, SH Jung, ... The Lancet Haematology 2 (2), e66-e74, 2015 | 103 | 2015 |
| Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group E Tse, TSY Chan, LP Koh, WJ Chng, WS Kim, T Tang, ST Lim, AKW Lie, ... Bone marrow transplantation 49 (7), 902-906, 2014 | 97 | 2014 |
| Production of pseudotyped particles to study highly pathogenic coronaviruses in a biosafety level 2 setting JK Millet, T Tang, L Nathan, JA Jaimes, HL Hsu, S Daniel, GR Whittaker Journal of visualized experiments: JoVE, 10.3791/59010, 2019 | 87 | 2019 |
| Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first … SH Lim, JY Hong, ST Lim, H Hong, J Arnoud, W Zhao, DH Yoon, T Tang, ... Annals of Oncology 28 (9), 2199-2205, 2017 | 83 | 2017 |
| Curating a COVID-19 data repository and forecasting county-level death counts in the United States N Altieri, RL Barter, J Duncan, R Dwivedi, K Kumbier, X Li, R Netzorg, ... PubPub, 2021 | 79 | 2021 |
| Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma JQ Lim, D Huang, T Tang, D Tan, Y Laurensia, RJ Peng, EKY Wong, ... Leukemia 34 (12), 3413-3419, 2020 | 71 | 2020 |